Fred Hu

GenBio.AI, Inc. (GenBio AI) is an innovative global startup dedicated to developing the world's first AI-driven Digital Organism, an integrated system of multiscale foundation models for predicting, simulating, and programming biology at all levels. Our goal is to achieve comprehensive, actionable empirical understandings of the mechanisms underlying all organismal physiologies and diseases. This will pave the way for a new paradigm in drug design, bio-engineering, personalized medicine, and fundamental biomedical research, all powered by Generative Biology. Our founding team consists of world-renowned scientists and researchers in AI and Biology from prestigious institutions such as CMU, MBZUAI, WIS, alongside prominent financial investors. GenBio AI, a true global effort from day one, is establishing offices in Palo Alto, Paris, and Abu Dhabi.